- Kaerlev L, Teglbjaerg PS, Sabroe S, Kolstad HA, Ahiens W, Eriksson M, et al. Medical risk factors for small-bowel adenocarcinoma with focus on Crohn disease: a European populationbased case-control study. Scand J Gastroenterol 2001;3 6:641-6.
- Lewis JD, Deren JJ, Lichtenstein GR. Cancer risk in patients with inflammatory bowel disease. Gastroenterol Clin North Am 1999;28:459-77.
- Munkholm P, Langholz B, Davidsen M, Binder V. Intestinal cancer risk and mortality in patients with Crohn's disease. Gastroenterology 1993;105:1716-23.
- Arber N, Neugut AI, Weinstein IB, Holt P. Molecular genetics of small bowel cancer. Cancer Epidemiol Biomarkers Prev 1997;6:745-8.
- Chen CC, Neugut AI, Rotterdam H. Risk factors for adenocarcinomas and malignant carcinoids of the small intestine: preliminary findings. Cancer Epidemiol Biomarkers Prev 1994; 3:205-7.
- Kaerlev L, Teglbjaerg PS, Sabroe S, Kolstad HA, Ahrens W, Eriksson M, et al. Is there an association between alcohol intake or smoking and small bowel adenocarcinoma? Results from a European multi-center case-control study. Cancer Causes Control 2000; 11:791-7.
- Sellner F. Investigations on the significance of the adenomacarcinoma sequence in the small bowel. Cancer 1990;66:702-15.
- Vogelstein B, Kinzler KW. Carcinogens leave fingerprints. Nature 1992;355:209-10.
- Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Nad Acad Sci USA 1991;88:10124-8.
- Bressac B, Kew M, Wands J, Oztuik M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 1991;350:429-31.
- Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991;3 50:427-8.
- Suzuki H, Takahashi T, Kuroishi T, Suyama M, Ariyoshi Y, Takahashi T, et al. p53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking. Cancer Res 1992;52:734-6.
- Takahashi T, Takahashi T, Suzuki H, Hida T, Sekido Y, Ariyoshi Y, et al. The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern. Oncogene 1991;6:1775-8.
- Arai M, Shimizu S, Imai Y, Nakatsuru Y, Oda H, Oohara T, et al. Mutations of the Ki-ras, p53 and APC genes in adenocarcinomas of the human small intestine. Int J Cancer 1997;70390-5.
- Rashid A, Hamilton SR. Genetic alterations in sporadic and Crohn's-associated adenocarcinomas of the small intestine. Gastroenterology 1997;! 13:127-35.
- Sutler T, Arber N, Moss SF, Findling RI, Neugut AI, Weinstein IB, et al. Frequent K-ras mutations in small bowel adenocarcinomas. Dig Dis Sci 1996;41:115-8.
- Hall PA, Lane DP. p53 in tumour pathology: can we trust immunohistochemistry? Revisited! J Pathol 1994; 172:1-4.
- d'Errioc A, Taiolo E, Chen X, Vineis P. Genetic metabolic polymorphisms and the risk of cancer: a review of the literature. Biomarkers 1996; 1:149-73.
- Zhong S, Wyllie AH, Barnes D, Wolf CR, Spurr NK. Relationship between the GSTMl genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 1993;14:1821-4.
- Houlston RS, Tomlinson IPM. Polymorphisms and colorectal tumor risk. Gastroenterology 2001; 121:282-301.
- Lehman TA, Bennett WP, Metcalf RA, Welsh JA, Ecker J, Modali RV, et al. p53 mutations, ras mutations, and p55-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res 1991;51:4090-6.
- Khoury MJ, Flanders WD. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls! Am J Epidemiol 1996;144: 207-13.
- Yang Q, Khoury MJ, Flanders WD. Sample size requirements in case-only designs to detect gene- environment interaction. Am J Epidemiol 1997; 146:713-20.
- Garte S, Gaspari L, Alexandrie A-K, Ambrosone C, Autrup H, Autrup JL, et al. Metabolic gene polymorphism frequencies in normal control populations. Cancer Epidemiol Biomarkers Prev 2001; 10:1239-48.
- Neugut AI, Santos J. The association between cancers of the small and large bowel. Cancer Epidemiol Biomarkers Prev 1993;2:551-3.
- Soussi T. The p53 tumour suppressor gene: a model for molecular epidemiology of human cancer. Mol Med Today 1996;2:32-7.
- Welsh JA, Castren K, Vahakangas KH. Single-strand conformation polymorphism analysis to detect p53 mutations: characterization and development of controls. Clin Chem 1997; 43: 2251-5.
- Strange RC, Matharoo B, Faulder GC, Jones P, Cotton W, Elder JB, et al. The human glutathione S-transferases: a case-control study of the incidence of the GSTl O phenotype in patients with adenocarcinoma. Carcinogenesis 1991;12:25-8.
- World Health Organisation: Pathology and genetics. Tumours of the digestive system. In: Hamilton SR, Aaltonen LA, editors. Lyon: IARC Press; 2000. p. 70-74.
Glutathione S -transferase Genotype and p53 Mutations in Adenocarcinoma of the Small Intestine
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.